Davern Capital Partners, LP Diversified Active

Location: NY, NY

CIK: 0002003147 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 14, 2026

Total Value ($000): $364,540 (100.0% shares, 0.0% debt)

Holdings (17)

New Positions (4)

INSM INSMED INC 8.2%

Value ($000) $29,853 Shares 182,562 Est. Cost $159.03 Unrealized 0.0%

GENB GENERATE BIOMEDICINES INC 2.0%

Value ($000) $7,398 Shares 591,800 Est. Cost $12.50 Unrealized —

PRCT PROCEPT BIOROBOTICS CORP 1.8%

Value ($000) $6,533 Shares 261,200 Est. Cost $29.57 Unrealized 0.0%

GPCR STRUCTURE THERAPEUTICS INC 1.7%

Value ($000) $6,095 Shares 126,461 Est. Cost $48.20 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INSM	INSMED INC	182,562	$29,853	8.2%	$159.03	0.0%	COM PAR $.01	457669307
GENB	GENERATE BIOMEDICINES INC	591,800	$7,398	2.0%	$12.50	—	COM SHS	370920100
PRCT	PROCEPT BIOROBOTICS CORP	261,200	$6,533	1.8%	$29.57	0.0%	COM	74276L105
GPCR	STRUCTURE THERAPEUTICS INC	126,461	$6,095	1.7%	$48.20	—	SPONSORED ADS	86366E106

Increased Positions (7)

LLY ELI LILLY & CO 6.9%

Value ($000) $25,090 (+181.1%) Shares 27,279 (+228.4%) Est. Cost $1019.21 Unrealized +2.7%

NTRA NATERA INC 7.9%

Value ($000) $28,792 (+59.8%) Shares 143,966 (+83.0%) Est. Cost $216.43 Unrealized +4.4%

IONS IONIS PHARMACEUTICALS INC 8.0%

Value ($000) $29,053 (+54.0%) Shares 386,903 (+62.2%) Est. Cost $77.79 Unrealized +5.2%

MLYS MINERALYS THERAPEUTICS INC 3.3%

Value ($000) $12,113 (+58.5%) Shares 447,153 (+112.3%) Est. Cost $35.48 Unrealized -11.6%

VRDN VIRIDIAN THERAPEUTICS INC 1.6%

Value ($000) $5,916 (-27.3%) Shares 302,457 (+15.6%) Est. Cost $27.89 Unrealized +10.6%

ABVX ABIVAX SA 2.4%

Value ($000) $8,699 (+33.0%) Shares 78,125 (+61.1%) Est. Cost $125.94 Unrealized —

LEGN LEGEND BIOTECH CORP 6.5%

Value ($000) $23,784 (+3.5%) Shares 1,314,748 (+24.4%) Est. Cost $21.02 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
LLY	ELI LILLY & CO	27,279 (+228.4%)	$25,090 (+181.1%)	6.9%	$1019.21	+2.7%	COM	532457108
NTRA	NATERA INC	143,966 (+83.0%)	$28,792 (+59.8%)	7.9%	$216.43	+4.4%	COM	632307104
IONS	IONIS PHARMACEUTICALS INC	386,903 (+62.2%)	$29,053 (+54.0%)	8.0%	$77.79	+5.2%	COM	462222100
MLYS	MINERALYS THERAPEUTICS INC	447,153 (+112.3%)	$12,113 (+58.5%)	3.3%	$35.48	-11.6%	COM	603170101
VRDN	VIRIDIAN THERAPEUTICS INC	302,457 (+15.6%)	$5,916 (-27.3%)	1.6%	$27.89	+10.6%	COM	92790C104
ABVX	ABIVAX SA	78,125 (+61.1%)	$8,699 (+33.0%)	2.4%	$125.94	—	SPONSORED ADS	00370M103
LEGN	LEGEND BIOTECH CORP	1,314,748 (+24.4%)	$23,784 (+3.5%)	6.5%	$21.02	—	SPONSORED ADS	52490G102

Exited Positions (1)

CGON CG ONCOLOGY INC 1.8%

Value ($000) $6,726 Shares 162,005 Est. Cost $41.38 Unrealized +26.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG ONCOLOGY INC	162,005	$6,726	1.8%	$41.38	+26.7%	—	156944100

Decreased Positions (6)

BNTX BIONTECH SE 7.4%

Value ($000) $27,113 (-23.3%) Shares 305,055 (-17.8%) Est. Cost $95.20 Unrealized —

RPRX ROYALTY PHARMA PLC 6.8%

Value ($000) $24,945 (-23.2%) Shares 520,009 (-38.1%) Est. Cost $38.13 Unrealized +10.9%

PFE PFIZER INC 12.3%

Value ($000) $44,758 (-12.0%) Shares 1,593,942 (-22.0%) Est. Cost $25.03 Unrealized +4.6%

REGN REGENERON PHARMACEUTICALS 9.5%

Value ($000) $34,614 (-14.5%) Shares 44,800 (-14.5%) Est. Cost $678.68 Unrealized +13.3%

ARGX ARGENX SE 7.0%

Value ($000) $25,592 (-14.7%) Shares 35,045 (-1.8%) Est. Cost $840.95 Unrealized —

ROIV ROIVANT SCIENCES LTD 6.6%

Value ($000) $24,193 (+8.4%) Shares 873,398 (-15.1%) Est. Cost $19.73 Unrealized +22.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BNTX	BIONTECH SE	305,055 (-17.8%)	$27,113 (-23.3%)	7.4%	$95.20	—	SPONSORED ADS	09075V102
RPRX	ROYALTY PHARMA PLC	520,009 (-38.1%)	$24,945 (-23.2%)	6.8%	$38.13	+10.9%	SHS CLASS A	G7709Q104
PFE	PFIZER INC	1,593,942 (-22.0%)	$44,758 (-12.0%)	12.3%	$25.03	+4.6%	COM	717081103
REGN	REGENERON PHARMACEUTICALS	44,800 (-14.5%)	$34,614 (-14.5%)	9.5%	$678.68	+13.3%	COM	75886F107
ARGX	ARGENX SE	35,045 (-1.8%)	$25,592 (-14.7%)	7.0%	$840.95	—	SPONSORED ADR	04016X101
ROIV	ROIVANT SCIENCES LTD	873,398 (-15.1%)	$24,193 (+8.4%)	6.6%	$19.73	+22.5%	SHS	G76279101